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Abstract Phagocytosis is an essential mechanism for
clearance of pathogens, dying cells, and other unwanted
debris in order to maintain tissue health in the body.
Macrophages execute this process in the peripheral immune
system but in the brain microglia act as resident macro-
phages to accomplish this function. In the peripheral
immune system, macrophages secrete Milk Fat Globule
Factor-E8 (MFG-E8) that recognizes phosphatidylserine
“eat me” signals expressed on the surface of apoptotic cells.
MFG-E8 then acts as a tether to attach the apoptotic cell to
the macrophage and trigger a signaling cascade that
stimulates the phagocyte development, allowing the mac-
rophage to engulf the dying cell. When this process
becomes disrupted, inflammation and autoimmunity can
result. MFG-E8 resides in the brain as well as in the
periphery, and microglia express MFG-E8. However, the
function of MFG-E8 in the brain has not been elucidated.
We measured MFG-E8 production in the BV-2 microglial
cell line and the role of this protein in the recognition and
engulfment of apoptotic SY5Y neuroblastoma cells. BV-2
cells produced and released MFG-E8, which apoptotic
SY5Y cells and the chemokine fractalkine further stimulat-
ed. Furthermore, MFG-E8 increased phagocytosis of
apoptotic SY5Y cells, and a dominant negative form of
MFG-E8 inhibited phagocytosis by BV-2 cells. Finally,
brain MFG-E8 levels were altered in a mouse model of
Alzheimer’s disease. Our data suggest that MFG-E8 acts in
the brain via microglia to aid in clearance of apoptotic
neurons, and we hypothesize that a dysregulation of this
process may be involved in neurodegenerative disease.
Keywords MFG-E8.microglia.phagocytosis.apoptosis.
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Introduction
Apoptotic cells and potentially toxic materials are the result
of neurodegenerative diseases and normal aging processes
(Mochizuki et al. 1996; Su et al. 1994; Thomas et al. 1995;
Zhang et al. 1995). The efficient removal of apoptotic
material is of utmost importance for protecting the
surrounding tissue from damage due to released proteins
from dying cells (Savill and Fadok 2000). Therefore, it is
critical that immune cells are capable of recognizing
apoptotic cells so that they may be efficiently removed
from the tissue. During apoptotic cell death, a redistribution
of plasma membrane phospholipids occurs which exposes
the normally inward facing phospholipid phosphatidylser-
ine (PS) on the surface of the dying cell. In turn, the PS acts
as an “eat me” signal for phagocytes to recognize,
triggering a cytoskeletal rearrangement in the phagocyte
and the engulfment of the apoptotic cell (Henson et al.
2001). This engulfment not only sequesters potentially
harmful cellular products from surrounding tissue, it
suppresses proinflammatory cytokines to create an anti-
inflammatory environment to further protect the tissue
(Fadok et al. 1998).
The mechanics of PS-triggered phagocytosis have been
studied in some detail in the peripheral immune system,
where phagocytes recognize the exposed PS on apoptotic
cells either directly through a PS receptor (Fadok et al.
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fat globule EGF factor-8 (MFG-E8; Hanayama et al. 2002)
and Growth Arrest Specific Gene-6 (Chen et al. 1997; Hall
et al. 2005). MFG-E8, shown to be released by macro-
phages, recognizes and binds PS on apoptotic cells,
allowing MFG-E8 to then engage an integrin receptor
(αvβ3 or αvβ5) on the macrophage forming a tether between
the two cells (Hanayama et al. 2002). This triggers a
conformational change in the integrin receptor that signals
the recruitment of the CrkII-DOCK180-Rac1 complex and
thus the activation of Rac1 (Akakura et al. 2004; Albert et
al. 2000). The result is cytoskeletal reorganization in the
macrophage and its transformation into a phagocyte capable
of removing the apoptotic cell. However, when interference
with this tethering occurs, such as insufficient production of
MFG-E8, a proinflammatory state is created, evident in
MFG-E8
−/− mice that show the symptoms of an autoim-
mune disorder resembling systemic lupus erythematosus
(Hanayama et al. 2004).
While a significant amount of work supports this
mechanism in the peripheral immune system, no studies
have been done to examine a role for MFG-E8 in the
process of apoptotic cell phagocytosis in the brain. Micro-
glia, which are similar to macrophages in the periphery of
the body, act as the phagocytic cells in the brain to remove
harmful material and dying cells (Garden and Moller 2006;
Stolzing and Grune 2004; Witting et al. 2000), but little is
known about MFG-E8 and microglia function. MFG-E8 is
expressed in the brain (Boddaert et al. 2007; Hanayama et
al. 2004), and one report indicates fractalkine (CX3CL1)
treatment of cultured microglia increases MFG-E8 mRNA
levels (Leonardi-Essmann et al. 2005). Fractalkine is a 95-
kDa chemokine expressed by neurons throughout the brain
in both membrane-bound and soluble forms (Harrison et al.
1998). The membrane-bound protein is cleaved to its
soluble form following cell stress or injury, which then
acts as a chemoattractant for T cells, monocytes, and
potentially microglia (Bazan et al. 1997). This is supported
by the observation that microglia are the only cells in the
brain that express CX3CR1, the fractalkine receptor
(Harrison et al. 1998). In the periphery, fractalkine
stimulates MFG-E8 production by peritoneal macrophages
and increases the phagocytosis of apoptotic thymocytes
(Miksa et al. 2007). Likewise, studies report abnormal
levels of fractalkine in neurodegenerative diseases such as
Alzheimer’s disease (AD) and AIDS-associated dementia
(Erichsen et al. 2003; Kim et al. 2008), therefore suggesting
a potential role for MFG-E8 regulation in the progress of
these diseases. However, the function of MFG-E8 in the
brain is currently unknown.
In the present study, we investigated the hypothesis that
MFG-E8 is produced by microglia and regulates the ability
of microglia to phagocytose apoptotic neurons. In order to
test this potential mechanism, we utilized the BV-2 micro-
glia cell line and the SY5Y human neuroblastoma cell line
as a model system for glial–neuronal interactions. We report
here that BV-2 production of MFG-E8 can be modulated by
the presence of apoptotic SY5Y cells as well as by
fractalkine. In addition, we studied the phagocytosis of
apoptotic SY5Y cells by BV-2 cells in the presence of
MFG-E8 or a dominant negative form of the protein.
Finally, we report altered levels of MFG-E8 protein in the
brains of Tg2576 mice, a mouse model of Alzheimer’s
disease overexpressing APP(swe). Our findings indicate a
conserved mechanism for MFG-E8-mediated clearance of
apoptotic cells in the brain, as well as implications of a
possible role for this protein in neurodegenerative diseases
like AD.
Materials and methods
Materials
Both recombinant mouse fractalkine and recombinant
mouse MFG-E8 (R&D Systems, Minneapolis, MN, USA)
were resuspended in sterile phosphate-buffered saline
(PBS) at 10 μg/ml and used at the concentrations indicated.
Antimouse MFG-E8 antibody (R&D Systems, Minneapo-
lis, MN, USA) was reconstituted at 0.2 mg/ml in sterile
PBS and used at a final concentration of 0.2 μg/ml. Bovine
serum albumin (BSA), fraction V (Sigma, St. Louis, MO,
USA), was resuspended at 1 mg/ml in sterile PBS and used
at a final concentration of 4 μg/ml. The plasmid for the
dominant negative form of MFG-E8 (D89E) was a
generous gift from Dr. Shigekazu Nagata (Osaka University
Medical School, Osaka, Japan), and the Flag-tagged D89E
was expressed in human 293T cells using FuGene 6
transfection reagent (Roche Diagnostics Co, Indianapolis,
IN, USA). The D89E protein secreted into the medium was
purified using anti-Flag M2 affinity gel (Sigma) as
recommended by the manufacturer.
Cell culture
BV-2 cells, a murine microglial cell line, were originally
derived by Dr. Elisabetta Blasi (Blasi et al. 1990) and
cultured as previously described (Petrova et al. 1999). SH-
SY5Y cells, a human neuroblastoma cell line, were
obtained from the American Type Culture Collection
(Manassas, KS, USA). Both cell lines were maintained in
DMEM/F-12 media containing 10% fetal bovine serum
(HyClone, Logan, UT, USA), 2 mM glutamine, and anti-
biotics [100 U/ml penicillin and 100 μg/ml streptomycin
(Invitrogen, Carlsbad, CA, USA)] and incubated at 37°C
with 5% carbon dioxide.
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For dose curve and time course experiments, cells were
trypsinized (0.25% trypsin, 0.53 mM ethylenediaminetetra-
acetic acid (EDTA) for 5 min at 37°C) and seeded at a
density of 2.5×10
5 cells per well (BV-2) or 1×10
5 cells per
well (SY5Y) in 12-well tissue culture plates. For coculture
experiments, SY5Y cells were cultured for 1 day in
advance of the experiment. After 24 h, BV-2 cells were
cultured with serum in the same wells as SY5Y cells so that
the cells were able to share the same culture media and
engage in direct cell–cell contact. In the case of UV-treated
cultures, SY5Y cells were exposed to 50 J/m
2 of UV light
for 20 s with a Stratalinker 1200 UV crosslinker 1 h prior to
coculture. At the indicated time points, conditioned media
was collected, centrifuged at 3,000×g for 3 min at 4°C, and
supernatants were collected. Cells were washed one time
with PBS then 100 μl of lysis buffer (20 mM Tris pH=8,
2 mM EDTA, 0.5% Triton X-100, 1 mM phenylmethane-
sulfonylfluoride, 1 μg/ml leupeptin, 2 mM sodium ortho-
vanadate) was added. Cell lysates were sonicated for 8 s on
ice, centrifuged at 10,000×g for 10 min at 4°C, and
supernatants were analyzed by Western blotting.
Cell viability assays
The combination of two cell viability assays allowed the
determination of a point when cells were dying but still
maintained membrane integrity. The number of viable cells
with and without UV radiation was determined using the
CellTiter 96 AQueous One Solution Cell Proliferation
Assay (Promega, Madison, WI, USA). This assay, known
as the MTS assay, utilizes the chemical reduction of a
tetrazolium substrate by the NADPH or NADH present in
living cells. Therefore, a higher number of living cells in a
sample results in more formation of a color product at
490 nm. The assay was performed according to manufac-
turer instructions. To assess the effect of UV radiation on
the membrane integrity of SY5Y cells, a lactate dehydro-
genase (LDH) assay was performed on the conditioned
media from control and UV-exposed cells according to
manufacturer instructions (Sigma). The assay measures
released LDH by its ability to convert NAD to NADH,
which in turn reacts with a tetrazolium dye substrate. The
optical densities (OD) of the colored product were
measured at 490 nm.
Western blotting
Western blotting was carried out as previously described
(Petrova et al. 1999). Briefly, cell lysates (1:2) and media
(1:3) were prepared in sodium dodecyl sulfate (SDS)
containing sample buffer, and equal volumes of both cell
lysates and media were separated by 10–14.5% SDS-
polyacrylamide gel electrophoresis (SDS-PAGE; Bio-Rad,
Hercules, CA, USA). Proteins were transferred to Immobi-
lon-P membranes (Millipore, Billerica, MA, USA), and
membranes were probed with rabbit polyclonal antimouse
MFG-E8 primary antibody (0.2 μg/ml, R&D Systems) or
mouse monoclonal anti-β-actin (1:50,000 dilution, Sigma)
overnight at 4°C. Membranes were then probed with goat
antirabbit (1:5,000) or goat antimouse (1:2,000) horseradish-
peroxidase-conjugated secondary antibody (Jackson Immu-
noResearch Laboratories, West Grove, PA, USA). Protein
bands were detected using SuperSignal West Pico Chemilu-
minescent Substrate (Pierce, Rockford, IL, USA). Images of
blots were acquired for quantification using Kodak 440
digital imager and analyzed with Kodak Molecular Imaging
software (Kodak, New Haven, CT, USA).
Phagocytosis assay
Phagocytosis by BV-2 cells was assayed using the pHrodo
Escherichia coli BioParticles Conjugate assay (Molecular
Probes, Eugene, OR, USA) according to manufacturer
instructions. Briefly, BV-2 cells were seeded at 5×10
5 cells
per well in black 96-well tissue culture plates for 24 h prior
to the assay. To prep BioParticles, 2.5 ml of Hank’s
buffered saline solution with an additional 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (Invitrogen,
Carlsbad, CA, USA) at a pH of 6.8 was used for
reconstitution. BioParticles were sonicated in a bath
sonicator at 30% intensity three times for 20 s each.
BioParticles were examined by light microscopy on a
hemocytometer to ensure dispersion. Recombinant mouse
MFG-E8 (100 ng/ml), D89E (4 μg/ml), or BSA (negative
control, 4 μg/ml) was added to BioParticles and vortexed.
Media was then removed from the cells and BioParticles
were added along with treatments. Each condition was
composed of five replicates. A negative control of wells
containing no cells was used to calculate background
fluorescence and was subtracted from other wells. The
positive control was BV-2 cells treated with BioParticles
alone. Plates were read on a SpectraMax fluorescent plate
reader, excitation 550 nm and emission 600 nm. Data
shown are representative of four separate experiments.
Imaging
SY5Y cells were subcultured for 3 days until cells were
approximately 70–80% confluent. Media was then replaced
with fresh complete media containing 7.5 μM CellTracker
Green 5-chloromethylfluorescein diacetate (Molecular
Probes) made from a 10-mM dimethyl sulfoxide (DMSO)
stock. After 30 min of incubation at 37°C and 5% CO2,
media was exchanged for normal media for an additional
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slides (BD Transduction Labs) at a density of 5×10
4 cells
per milliliter and allowed to incubate for 24 h. Six hours
prior to coculture, SY5Y cells were exposed to 50 J/m
2 of
UV light for 20 s as described above when indicated and
returned to incubation. One hour prior to coculture, media
on 70–80% confluent BV-2 cells was replaced with fresh
complete media containing 4 μM CellTracker Red CMTPX
(Molecular Probes) made from a 10 mM DMSO stock for
30 min followed by normal fresh media for another 30 min.
BV-2 cells were then seeded on top of SY5Y cells at a
density of 2.5×10
4 cells per milliliter and treated with
MFG-E8 or D89E where indicated. After 2 h, cells were
washed one time with sterile PBS, fixed using 4%
paraformaldehyde, washed once more with sterile PBS, and
mounted with Vectashield mounting medium containing
4’,6-diamidino-2-phenylindole (DAPI; Vector Laboratories,
Burlingame, CA, USA).
To analyze the amount of phagocytosis that occurred in
this coculture, four images per condition were randomly
captured and then analyzed in Metamorph to determine the
percent colocalization of red and green labels. This was
repeated three times and data were pooled.
Mouse brain tissue preparation
Hemibrain homogenates from Tg2576 mice (Hsiao et al.
1996) and age-matched wild-type littermates were a
generous gift from Dr. Robert Vassar (Northwestern
University, Chicago, IL, USA), and samples were prepped
as previously described (Oakley et al. 2006). Briefly,
hemibrains were homogenized in four volumes of PBS
containing protease inhibitor cocktail (Calbiochem, La
Jolla, CA, USA). Protein concentrations were determined
using a BCA kit (Pierce), and 10–20 μg of protein analyzed
by Western blot as outlined above.
Statistical analysis
Data were analyzed using a two-tailed Student’s t test for
paired data or using one-way analysis of variance followed
by Tukey’s post hoc tests of multiple comparisons to
determine significant differences between groups. Statisti-
cal significance was established when P<0.05.
Results
A microglial cell line produces MFG-E8 that is stimulated
by apoptotic neurons and fractalkine
We hypothesize that microglia produce and release MFG-
E8 which aids in the clearance of apoptotic cells in the
brain by enabling the recognition and engagement of
microglia with dying cells, a similar mechanism to that
observed in the peripheral immune system (Hanayama et al.
2002). Furthermore, we suspect that apoptotic cells stimu-
late an increase in MFG-E8 so that efficient recognition and
clearance of the dying cells is enabled. In order to test this
idea, we utilized a coculture system comprised of the
murine BV-2 microglial cell line and the human SY5Y
neuroblastoma cell line to simulate the glial–neuronal
environment, and we then measured MFG-E8 released
from BV-2 cells when cocultured with either healthy or
dying SY5Y cells. To induce apoptosis in SY5Y cells,
SY5Y cultures were exposed to UV light prior to coculture.
Therefore, we first verified that exposure of SY5Y cells to
20 s of UV light induced cell death as determined by the
MTS and LDH assays (Fig. 1a,b). In the MTS assay
(Fig. 1a), media containing Triton X-100 added to SY5Y
cells served as a positive control, which yielded similar
levels of MTS production as a negative control containing
no cells. MTS production measured at 0, 3, 6, 9, and 12 h
after the 20-s UV treatment showed a reduction in MTS as
soon as 3 h, leveling off at 9–12 h. LDH release measured
at the same time points indicated membrane disruption
beginning at 3 h (Fig. 1b). To establish the coculture, we
plated SY5Y cells for 24 h prior to coculture and exposed
cells to 20 s of UV light 1 h prior to coculture for 12 or
24 h. Apoptotic SY5Y cells stimulated an increased level of
MFG-E8 production at both 12- and 24-h time points
(Fig. 1c), indicating that apoptotic cells elicit a robust
upregulation in MFG-E8 production and release from a
microglial cell line. Interestingly, MFG-E8 levels increased
in the control samples from 12 to 24 h (Fig. 1c) as well as
at 48 h in culture (data not shown). This indicates an
endogenous production of MFG-E8 in these cells that
accumulates over time. While the exact mechanism of this
finding is unknown, the effect may be a function of
increased cell density in the culture system, as the MFG-
E8 protein levels were normalized to β-actin. Alternatively,
cell death due to extended time in culture along with
increased cell density could be inducing a rise in MFG-E8
production that is further stimulated by the addition of
apoptotic SY5Y cells. AWestern blot of the individual cells
types insured all MFG-E8 detected in these assays came
from BV-2 cells and not SY5Y cells. In both media and
lysate fractions, we detected MFG-E8 only in BV-2 cells
(Fig 1d).
Because fractalkine is likely released in response to
cellular stress and apoptosis (Harrison et al. 1998), we
hypothesized that this chemokine may be responsible for
some, if not all, of the increase in MFG-E8 production by
BV-2 cells in coculture with apoptotic SY5Y cells. In
addition, a recent study published by Miksa and colleagues
indicates that fractalkine is capable of increasing MFG-E8
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cells also exhibit prophagocytic behavior following treat-
ment with fractalkine (Miksa et al. 2007). This finding
combined with a previous report (Leonardi-Essmann et al.
2005) that MFG-E8 mRNA levels increased in microglial
cells following treatment with the chemokine fractalkine
led us to investigate whether the fractalkine stimulation of
BV-2 cells could be involved in the increase in MFG-E8
levels seen in the coculture experiments above. To test this,
levels of MFG-E8 protein in BV-2 cell lysates and
conditioned media were measured following treatment with
100 ng/ml fractalkine. As shown in Fig. 2, Western blots
confirmed that fractalkine treatment for 24 and 48 h
stimulated MFG-E8 production and release above control
levels (Fig. 2a–c). The level of induction above control
seen at 48 h is not as robust as that seen at 24 h, suggesting
that a maximal level of stimulation is reached before 48 h
following a single dose of recombinant fractalkine.
MFG-E8 increases phagocytosis by a microglial cell line
After we confirmed MFG-E8 production by a microglial
cell line and regulation by both fractalkine and coculture
with an apoptotic neuronal cell line, we next investigated
the ability of MFG-E8 to increase the phagocytic capacity
of microglia (Fig. 3). We hypothesized that adding
recombinant MFG-E8 to a phagocytosis assay would result
in more connections formed between BV-2 cells and the
material intended to be phagocytosed, thereby enabling the
engulfment of more particles. To first address this question,
we employed the pHrodo assay from Molecular Probes,
which measures the uptake of BioParticles, dead E. coli
particles tagged with a pH-sensitive dye which fluoresces
once it enters the intracellular environment. BV-2 cells were
untreated (positive control) or treated with 100 ng/ml
recombinant mouse MFG-E8, 4 μg/ml dominant negative
MFG-E8 (D89E), or 4 μg/ml BSA as an unrelated protein
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Fig. 1 Apoptotic neurons induce an increase in MFG-E8 release by
microglia. SY5Y cells were exposed to UV light for 20 s to induce
apoptosis, and the MTS assay (a) and LDH assay (b) were run to
confirm UV-induced cell death. Wells with no cells were used as a
negative control (c), Triton-X-100-treated cells were used as a positive
control (X). Results were measured at 0, 3, 6, 9, and 12 h after UV
exposure. For coculture experiments (c), SY5Y cells were exposed to
20 s of UV 1 h prior to coculturing with BV-2 microglial cells. Media
was collected from cultures 12 or 24 h after coculture and analyzed for
MFG-E8 by Western blot. Westerns were quantified by densitometry
and normalized to β-actin (C). A representative Western blot is shown
in d, demonstrating that MFG-E8 is detected only in BV-2 cells. The
data are mean±SEM of quadruplicate determinations and are repre-
sentative of three independent experiments. Significant difference is
from vehicle control, *p<0.05
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factor (EGF) domains E1 and E2, a proline–threonine (PT)-
rich domain, and two factor-VIII-homologous domains (C1
and C2; Fig. 3a). When MFG-E8 binds PS on the surface of
apoptotic cells, the protein then can interact with integrin
receptors on macrophages. Therefore, a point mutation in
the RGD motif of one EGF domain resulting in a dominant
negative form of MFG-E8, called D89E, does not bind to
PS (Hanayama et al. 2002) and effectively blocks the
function of the protein. D89E expressed in HEK293T cells
and purified from the conditioned media reacted with an
antibody to MFG-E8 and ran at the correct molecular
weight (Fig. 3b). Furthermore, D89E protein samples were
confirmed to be relatively pure by visualization on a silver-
stained SDS-PAGE gel, as indicated by a single visible
band (data not shown). The addition of MFG-E8 to the
pHrodo assay resulted in a 27.3±6.8% increase in phago-
cytosis (Fig. 3c). Conversely, the addition of D89E sup-
pressed phagocytosis in this assay by 65.8±18.4%. A
higher concentration of D89E (4 μg/ml) as compared to
recombinant MFG-E8 (100 ng/ml) was needed in order to
see an inhibition in phagocytosis, possibly due to the ability
of the endogenous MFG-E8 to potentially bind multiple PS
residues and thus tether multiple apoptotic cells or
BioParticles in this experiment. Therefore, an excess of
the dominant negative form of MFG-E8 was necessary to
flood the PS targets and block phagocytosis. To control for
the possibility that adding a protein at 4 μg/ml nonspecif-
ically inhibited phagocytosis, BSA added at an equivalent
concentration showed no significant decrease in BioParticle
engulfment.
Given that BV-2 cells showed phagocytic activity in the
pHrodo assay and that this activity increased in the
presence of MFG-E8 and decreased with D89E, we next
investigated the potential for BV-2 cells to engulf dying
neurons and the effect of MFG-E8 in this system (Fig. 4).
SY5Y cells and BV-2 cells were labeled by CellTracker
Green and CellTracker Red dyes as described in “Materials
and methods.” SY5Y cells cultured for 24 h prior to a 20-s
UV exposure and then cocultured with BV-2 cells for 6 h
after UV exposure were treated with MFG-E8 or D89E for
1 h and then cells were analyzed by fluorescent microscopy.
Colocalization of red BV-2 cells and green SY5Y cells
indicated phagocytosis. We observed very little phagocyto-
sis under control conditions where SY5Y cells were not
undergoing apoptosis (data not shown). However, phago-
cytosis increased with apoptotic SY5Y cells (Fig. 4a), and
treatment with 100 ng/ml MFG-E8 further enabled the
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Purified D89E (b) cross-reacts with an anti-MFG-E8 antibody and
runs at the same molecular weight as recombinant wild-type MFG-E8.
The BV-2 cells phagocytosed BioParticles in the pHrodo assay from
Molecular Probes after 2 h in culture (c). This phagocytosis was
increased with the addition of 100 ng/ml MFG-E8 and inhibited by
treatment with 4 μg/ml dominant negative D89E. Cells treated with a
4 μg/ml BSA control showed no difference from the untreated control.
The data are the mean±SEM from five replicates per experiment of
three separate experiments and are expressed as percent of untreated
control wells. Significant difference is from control, **p<0.001
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Fig. 2 MFG-E8 is production by microglia is upregulated by fractal-
kine. BV-2 microglia cells were treated with vehicle (C) or 100 ng/ml
fractalkine (F) for 24 or 48 h before lysates (a) and conditioned media
(b) were collected and analyzed for the presence of MFG-E8 by
Western blot (c). Western blots were quantified by densitometry and
normalized to β-actin. The data are mean±SEM of quadruplicate
determinations and are representative of three independent experiments.
Significant difference is from vehicle control, *p<0.05
J Neuroimmune Pharmacol (2008) 3:246–256 251 251engulfment of SY5Y cells (Fig. 4b,d). As in the pHrodo
assay, the presence of 4 μg/ml D89E inhibited phagocytosis
(Fig. 4c). In many cases in the MFG-E8-treated cells, green
SY5Y cells appeared fragmented inside red BV-2 cells
(Fig. 4d), and occasionally two nuclei resided in one BV-2
cell (data not shown). Quantification of the data (Fig. 4E)
showed that MFG-E8 treatment resulted in a significant
increase in colocalization compared to UV treatment alone,
and treatment with the D89E dominant negative protein
resulted in a significant decrease in colocalization. These
results support the idea that microglial phagocytosis is
mediated through an MFG-E8-dependent mechanism.
Tg2576 mice produce lower levels of brain MFG-E8
Data generated in the BV-2 cell culture system suggest that
MFG-E8 plays a similar role in the clearance of apoptotic
neurons in the brain as it does in the clearance of apoptotic
cells in the peripheral immune system. Defects in this
mechanism have been linked to several autoimmune and
inflammatory disorders in the peripheral immune system
(Asano et al. 2004; Hanayama et al. 2004, 2006; Miksa et al.
2006; Yamaguchi et al. 2008), so a reasonable hypothesis
would be that MFG-E8 may play a role in neurological
conditions as well. To begin to examine this idea, we
screened the Tg2576 mouse model of AD (Hsiao et al. 1996)
for changes in brain MFG-E8 production compared to age-
matched wild-type animals (Fig. 5). Whole brain homoge-
nates from 2-, 6-, 12-, and 18-month mice were compared by
Western blot analysis. Wild-type animals displayed an
increase in MFG-E8 levels with age that became significant
at 12 months. In contrast, Tg2576 animals showed much
lower levels of MFG-E8 that increased a small but
significant amount at 18 months, yet was still below wild-
type levels.
Discussion
In this study, we report several key findings. First, in a cell
culture model system of glial–neuronal interactions, apo-
ptotic neuroblastoma cells induce an increase in MFG-E8
production by the BV-2 microglial cell line. Second, we
demonstrate that MFG-E8 stimulates microglial phagocy-
Fig. 4 MFG-E8 increases and D89E decreases the phagocytosis of
apoptotic neurons by microglia. SY5Y cells labeled with CellTracker
green were exposed to 20 s of UV light, and 5 h later, CellTracker red-
labeled BV-2 cells were cocultured with SY5Y cells for 1 h. Slides
were then coverslipped with VectaShield containing DAPI for
imaging. At the time of coculture, cells were treated with vehicle (a),
100 ng/ml MFG-E8 (b and inset in d), or 4 μg/ml D89E (c). Images
were analyzed for colocalization of red and green dye with Image-
Quant and results are expressed as percent colocalization, which is
defined as the overlap area of red and green staining as compared to
total area analyzed. The data (d) are the mean±SEM from three
independent experiments consisting of six randomly selected fields
analyzed per experiment. The scale bar is equal to 100 μm for a–c and
50 μm for the inset in d. Significant difference is from vehicle-treated
cells, **p<0.001; *p<0.05
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dominant negative form of MFG-E8, which acts to mask
the phosphatidylserine expressed on the apoptotic cell,
blocks this phagocytic activity. We also show that treatment
of BV-2 cells with the chemokine fractalkine (CXCL3)
increases MFG-E8 protein production by these cells,
suggesting a potential mechanism that drives the increase
of phagocytosis of apoptotic SY5Y cells by BV-2 cells.
Finally, when investigating a possible role for MFG-E8 in
the progression of AD, we discovered that brain MFG-E8
production is suppressed in the Tg2576 mouse model of
AD. These data support a role for MFG-E8 in regulation of
phagocytosis by microglia (see Fig. 6) and implicate this
protein in the disease process of AD.
Although the mechanism by which microglia recognize
apoptotic cells in the brain has not been completely
resolved, several important signals have been identified,
such as the importance of PS expression, interaction with
the vitronectin receptor on microglia, the CD36 scavenger
receptor, TREM-2, and most recently Gas6 (Grommes et al.
2008; Stolzing and Grune 2004; Takahashi et al. 2005;
Witting et al. 2000). Like MFG-E8, Gas6 binds to PS
(Ishimotoetal.2000) and links apoptotic cells to phagocytes.
In the periphery, a link between Gas6 and MFG-E8 has been
identified, referred to as the “tether and tickle” (Hoffmann et
al. 2001). The “tether,” recognition and binding of apoptotic
cells to phagocytes, is often mediated by integrins, such as in
MFG-E8 binding, and is not sufficient for engulfment. The
“tickle” signals an internalization of bound particles and
induction of downstream signaling cascades and functions
through the receptor tyrosine kinase Mer (Scott et al. 2001;
Todt et al. 2004). Taken together, strong adhesion through
tethering with molecules like MFG-E8 in combination with
the conversion of this binding to a signaling event through
tickling molecules such as Gas6 create a multiple step model
required for proper clearance of apoptotic cells. Likewise,
Gas6 was shown to function in microglia to aid in
phagocytosis via Rac activation and suppress inflammation
as it does in the peripheral immune system (Grommes et al.
2008). However, while association of apoptotic cells and
microglia was enhanced by the addition of Gas6 in the study
of Grommes et al., phagocytosis was not enhanced, indicat-
ing that the Gas6–Mer interaction is not sufficient for
engulfment. Based on our findings in the current study, we
suggest that Gas6 and MFG-E8 are fulfilling their roles in the
brain of the tether–tickle scenario modeled in the periphery.
Treatment of microglia with the chemokine fractalkine
w a sp r e v i o u s l yl i n k e dt oM F G - E 8m R N Ae x p r e s s i o n
(Leonardi-Essmann et al. 2005), and we have extended
these findings to MFG-E8 protein production and release
by microglial cells. Fractalkine is known to be released
from injured neurons, and the addition of fractalkine to
microglia has been reported to induce chemotaxis resulting
in a threefold increase in the number of glial cells, a
response which is blocked by antifractalkine antibodies
(Harrison et al. 1998). This recruitment of microglia to a
site of neuronal injury coupled with the induction of MFG-
E8 by fractalkine led us to hypothesize that fractalkine
stimulation of MFG-E8 played a role in enabling micro-
apoptosis
Phosphatidylserine
MFG-E8
phagocytosis
microglia
neuron
Fig. 6 Proposed model for MFG-E8-mediated phagocytosis of
apoptotic neurons by microglia. Cell stress from normal aging,
disease, or injury induces apoptosis in neurons, resulting in a
redistribution of the plasma membrane and the exposure of PS on
the cell surface. Microglia produce and release MFG-E8 to scan the
environment for apoptotic cells. Once PS is detected, MFG-E8 binds
to it, allowing it to bind back to an integrin receptor on the microglia
thus acting as a tether. This association of the cells allows the
microglia to develop into a phagocyte and engulf the apoptotic
neuron, ultimately protecting the surrounding tissue from potentially
harmful cellular debris
Fig. 5 Tg2576 mice produce lower levels of brain MFG-E8 than
wild-type mice. Whole brain homogenates from Tg2576 mice of
various ages (3, 6, 9, 12, 18 months) and from wild-type age-matched
littermates were probed for MFG-E8 levels by Western blot (a). Blots
were quantified by densitometry and normalized to β-actin (b).
Significant difference is shown, **p<0.001; *p<0.05
J Neuroimmune Pharmacol (2008) 3:246–256 253 253glial-mediated phagocytosis of apoptotic neurons. The
robust increase in MFG-E8 induced by coculturing an
apoptotic neuronal cell line with a microglial cell line
supports this theory and suggests that this protein may be
involved in the recognition of apoptotic cells in the brain in
a similar way as in the periphery.
Our data showing that MFG-E8 added to a BioParticle
phagocytosis assay with BV-2 cells leads to an increase in
phagocytosis also support our hypothesis. Furthermore, the
phagocytosis of apoptotic SY5Y cells by BV-2 cells is
increased in the presence of MFG-E8, and the dominant
negative form of MFG-E8 inhibits phagocytosis in both of
these assays. In the peripheral immune system, macrophages
cocultured with apoptotic cells show an increase of about
40% in the phagocytosis of PS-expressing cells when MFG-
E8 is added that is similar in scale to the roughly 27%
increase in phagocytosis that we report here (Hanayama et
al. 2002). The involvement of endogenous MFG-E8 pro-
duced by BV-2 cells may account for the high basal levels of
phagocytosis that we see in this assay, and therefore the
addition of recombinant MFG-E8 yields a modest stimula-
tion of phagocytic activity. In addition, masking the PS with
D89E, the dominant negative form of the protein, inhibits
phagocytosis by about 60%, the same magnitude of
inhibition that we found in microglia (Hanayama et al.
2002). Altogether, these data support the hypothesis that
MFG-E8 binds apoptotic neurons and enables their clearance
by microglia. To provide further support for this hypothesis,
future studies with primary microglia and neurons will be
important. Also, because our results implicate fractalkine in
stimulating MFG-E8 in microglia, the ability of fractalkine
to stimulate phagocytosis of apoptotic neurons by microglia
needs further examination.
There is evidence that MFG-E8 plays a role in the
pathological process of several diseases. In sepsis, several
cell types undergo apoptosis, and the inflammatory state
induced by severe infection downregulates the production
of MFG-E8. Interestingly, treatment with exosomes con-
taining MFG-E8 increased the clearance of apoptotic cells,
reduced levels of TNF-α and IL-6, and increased survival
in a cecal ligation model of sepsis in rats (Miksa et al.
2006). MFG-E8 has also been proposed to be involved in
intestinal mucosa repair, tumor growth, systemic lupus
erythematosus, and AD (Boddaert et al. 2007; Bu et al.
2007; Fens et al. 2008; Wu et al. 2006; Yamaguchi et al.
2008). A recent report shows MFG-E8 mRNA expression
was decreased in AD brains as compared to age-matched
controls, and less MFG-E8 was found in areas of abundant
plaques. In addition, the study suggested an MFG-E8-
dependent mechanism for phagocytosisofAβ1–42 (Boddaert
et al. 2007). Similarly, we found lower levels of MFG-E8
expression in the Tg2576 mouse model of AD, a model
which overexpresses the APP(swe) mutation.
The finding of low levels of MFG-E8 protein in the
Tg2576 mouse model of AD suggests that dysregulation of
the protein is somehow involved in the pathological process
of this disease. Previous research in this model shows that
fractalkine is also inhibited in these mice at 9 months and
returns to wild-type levels at 11 months (Duan et al. 2008).
Likewise, we have shown that fractalkine is capable of
regulating MFG-E8 production in microglial cells. Howev-
er, the low levels of MFG-E8 protein detected in young
Tg2576 mice suggests that something in this model is
acting to suppress the protein product. In the peripheral
immune system as well as in microglia, data show that LPS,
a toll-like receptor agonist, inhibits MFG-E8 production by
macrophages (Jinushi et al. 2007; Miyasaka et al. 2004).
Young Tg2576 mice have high levels of soluble Aβ, and
cognitive deficits are seen in these mice before plaque
deposition occurs (Lindner et al. 2006). It may be possible
that soluble Aβ species, which have been shown to activate
microglia, inhibit MFG-E8 production by a similar mech-
anism. As soluble Aβ accumulates into insoluble plaques in
this animal model, a corresponding rise in MFG-E8
production is seen, suggesting a shift back toward normal
MFG-E8 production or stimulation by apoptotic cells in the
brain tissue.
In conclusion, the data reported here have implicated
MFG-E8 in the clearance of apoptotic material in the
brain by microglia. In addition, our finding that fractal-
kine stimulates MFG-E8 protein production, combined
with published reports of altered fractalkine levels in
diseases such as AD and HIV-1-associated dementia,
indicates that MFG-E8 may play an important role in
signaling microglia for phagocytosis following neural
insults. This is also supported by our discovery of
suppressed MFG-E8 levels in the brains of the Tg2576
mouse model of AD. Further work on the mechanism of
MFG-E8 suppression in AD may uncover potential
therapeutic strategies for the treatment of AD and other
neurodegenerative diseases.
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